These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 15897536)

  • 1. Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force.
    U.S. Preventive Services Task Force
    Ann Intern Med; 2005 May; 142(10):855-60. PubMed ID: 15897536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Summaries for patients. Postmenopausal hormone replacement therapy to prevent chronic conditions: recommendations from the U.S. Preventive Services Task Force.
    U.S. Preventive Services Task Force
    Ann Intern Med; 2002 Nov; 137(10):I48. PubMed ID: 12435233
    [No Abstract]   [Full Text] [Related]  

  • 3. Summaries for patients. Hormone therapy to prevent chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force.
    Ann Intern Med; 2005 May; 142(10):I59. PubMed ID: 15897529
    [No Abstract]   [Full Text] [Related]  

  • 4. Postmenopausal hormone replacement therapy for the primary prevention of chronic condition. Recommendations and rationale. U.S. Preventive Services Task Force.
    USPSTF
    Am Fam Physician; 2003 Jan; 67(2):358-64. PubMed ID: 12562158
    [No Abstract]   [Full Text] [Related]  

  • 5. Postmenopausal hormone replacement therapy for primary prevention of chronic conditions: recommendations and rationale.
    U.S. Preventive Services Task Force
    Ann Intern Med; 2002 Nov; 137(10):834-9. PubMed ID: 12435221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health.
    Sturdee DW; Pines A; ; Archer DF; Baber RJ; Barlow D; Birkhäuser MH; Brincat M; Cardozo L; de Villiers TJ; Gambacciani M; Gompel AA; Henderson VW; Kluft C; Lobo RA; MacLennan AH; Marsden J; Nappi RE; Panay N; Pickar JH; Robinson D; Simon J; Sitruk-Ware RL; Stevenson JC
    Climacteric; 2011 Jun; 14(3):302-20. PubMed ID: 21563996
    [No Abstract]   [Full Text] [Related]  

  • 7. Postmenopausal hormone therapy before and after the women's health initiative study: what consequences?
    Mikkola TS; Clarkson TB; Notelovitz M
    Ann Med; 2004; 36(6):402-13. PubMed ID: 15513292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical appraisal of the Women's Health Initiative.
    Speroff L
    J Obstet Gynaecol Res; 2005 Apr; 31(2):80-93. PubMed ID: 15771632
    [No Abstract]   [Full Text] [Related]  

  • 9. Postmenopausal hormone replacement therapy for the primary prevention of chronic conditions: recommendations and rationale.
    Berg AO;
    Am J Nurs; 2003 Jun; 103(6):83-91. PubMed ID: 12802162
    [No Abstract]   [Full Text] [Related]  

  • 10. Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statement.
    U.S. Preventive Services Task Force
    Ann Intern Med; 2007 Mar; 146(5):361-4. PubMed ID: 17339621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menopausal hormone therapy for the primary prevention of chronic conditions: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Ann Intern Med; 2013 Jan; 158(1):47-54. PubMed ID: 23090711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Justification for the use of HRT in the long-term prevention of osteoporosis.
    Stevenson JC
    Maturitas; 2005 Jun; 51(2):113-26. PubMed ID: 15917151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal hormone replacement therapy and major clinical outcomes: a focus on cardiovascular disease, osteoporosis, dementia, and breast and endometrial neoplasia.
    Dick SE; DeWitt DE; Anawalt BD
    Am J Manag Care; 2002 Jan; 8(1):95-104; quiz 105-6. PubMed ID: 11814176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy post Women's Health Initiative study: where do we stand?
    Calleja-Agius J; Brincat MP
    Curr Opin Obstet Gynecol; 2008 Dec; 20(6):513-8. PubMed ID: 18989125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health risks after cessation of postmenopausal hormone therapy.
    Pines A; Sturdee D; Birkhäuser M;
    Climacteric; 2008 Jun; 11(3):179-80. PubMed ID: 18568782
    [No Abstract]   [Full Text] [Related]  

  • 16. Hormone replacement therapy in postmenopausal women.
    Prelevic GM; Kocjan T; Markou A
    Minerva Endocrinol; 2005 Mar; 30(1):27-36. PubMed ID: 15877011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Landmark hormone replacement therapy study stopped after finding more harms than benefits.
    Rollins G
    Rep Med Guidel Outcomes Res; 2002 Aug; 13(15):5-7. PubMed ID: 12553323
    [No Abstract]   [Full Text] [Related]  

  • 18. Lessons learned from the WHI: HRT requires a cautious and individualized approach.
    Aubuchon M; Santoro N
    Geriatrics; 2004 Nov; 59(11):22-6. PubMed ID: 15615157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menopausal hormone replacement therapy.
    Varner RE
    Curr Womens Health Rep; 2003 Oct; 3(5):410-7. PubMed ID: 12959701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.